Ultrasound test for fluid on the brain in babies
Treatments studied
Part of Brain & nervous system clinical trials.
This trial uses a special ultrasound with contrast to study fluid on the brain (hydrocephalus) in newborn babies. The aim is to learn more about the condition and improve treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a boy or girl under 1.5 years old
- You have been diagnosed with or are suspected of having hydrocephalus
- You are at least 26 weeks old since conception
- You are an inpatient at Children's Hospital of Philadelphia
- A parent or legal guardian can give permission
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new ultrasound technique to look at the brain of babies with hydrocephalus, a condition where fluid builds up in the brain. It may help doctors see the fluid and brain structures without using radiation or sedation.
This study tests a new, non-invasive way to monitor pressure in the brain for babies at risk of hydrocephalus. It uses a special contact lens and a small sticker, so no needles or surgery are needed.
This early-phase study tests a special ultrasound with an added contrast medicine (Lumason) during surgery for babies with developmental dysplasia of the hip (DDH). It aims to better see blood flow at the time of surgery, which may help guide and improve care.
This Phase 2 trial looks at a special ultrasound approach to better understand and measure portal hypertension—high pressure in the liver’s vein system—in children with long-term (chronic) liver disease. The results may help doctors track this condition more accurately and safely.
This study tests whether using ultrasound (a type of imaging) to guide the placement of a brain drain (ventricular catheter) is safe and effective for patients with newly diagnosed hydrocephalus (fluid on the brain). If you're already scheduled for the procedure, you may be able to join.
This trial uses a special ultrasound with a contrast agent to see how well a liver cancer treatment called TACE is working. It may help doctors better understand if the treatment is shrinking the tumor.
Hear when a new Hydrocephalus in Infants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.